|1.||Reppenhagen, S: 3 articles (10/2015 - 05/2007)|
|2.||Nöth, U: 3 articles (10/2015 - 05/2007)|
|3.||Sun, Wei: 3 articles (03/2012 - 10/2008)|
|4.||Tingart, M: 2 articles (10/2015 - 10/2015)|
|5.||Roth, A: 2 articles (10/2015 - 10/2015)|
|6.||Maus, U: 2 articles (10/2015 - 10/2015)|
|7.||Heiss, C: 2 articles (10/2015 - 10/2015)|
|8.||Jäger, M: 2 articles (10/2015 - 10/2015)|
|9.||Rader, C: 2 articles (10/2015 - 10/2015)|
|10.||Beckmann, J: 2 articles (10/2015 - 10/2015)|
03/01/2011 - "The study included 162 patients (223 hips; 61 females, 101 males; mean age 33.5 years, range 19-54 years) with stage II-III avascular necrosis of the femoral head according to the ARCO (Association Research Circulation Osseous) classification. "
06/01/2010 - "The study included 110 patients (138 hips; 41 females, 69 males; mean age 32.36 years, range 17-54 years) with stage IIA-IIIA nontraumatic avascular necrosis of the femoral head according to the system of the ARCO (Association Research Circulation Osseous). "
05/01/2015 - "Among them, 19 cases (23 hips) were steroid-induced, 25 cases (33 hips) were alcohol-induced, 6 cases (6 hips) were idiopathic; According to ARCO stage, 28 hips were at stage I, 34 hips were at stage II. All of them were diagnosed as femoral head necrosis by imaging examination before operation. "
07/01/2014 - "Perfusion of bone marrow stromal stem cells through optional artery can effective treat non-traumatic femoral head necrosis of ARCO I, II period, it can make the femoral circumflex artery and its branches increased thickening."
09/01/2012 - "A prospective study was carried out in patients with avascular necrosis of the femoral head, ARCO stage I-III, diagnosed by MRI imaging. "
04/01/2012 - "The current study evaluated the effectiveness of ESWT in reducing pain and in slowing down the progression of bone damage in 36 patients with unilateral AVNFH of stage Association Research Circulation Osseous (ARCO) I, II and III. At the beginning of the study, 10 hips were classified as stage I, 11 as stage II and 15 as stage III. Each treatment cycle included four sessions, with 2,400 impulses each administered at 0.50 mJ/mm(2), at 48-72 h intervals. "
10/01/2008 - "According to ARCO classification, there were 23 hips of stage II, 43 hips of stage III, and 1 hip of stage IV. The induced factors, the degree of pain, the duration of pain and commemorative symptoms were compared. "
03/01/2008 - "Correlations were observed between ARCO and hip pain (r=.34), between hip flexion ROM and hip pain (r=-.34), and between knee pain and time on the TUDS Test (r=-.35). "
10/01/2015 - "In ARCO stage III with infraction of the femoral head, the core decompression can be used for a short-term pain relief. "
04/01/2012 - "ESWT in ARCO stages I and II may help to prevent progression of the area of avascular necrosis and manage pain."
01/01/2014 - "Treatment of allergic rhinitis is associated with improved attention performance in children: the Allergic Rhinitis Cohort Study for Kids (ARCO-Kids)."
05/01/2015 - "Novel Risk Factors for Allergic Rhinitis in Korean Elementary School Children: ARCO-kids Phase II in a Community."
01/01/2014 - "In this ARCO-Kids (Allergic Rhinitis Cohort Study for Kids), consecutive pediatric patients with rhinitis symptoms underwent a skin prick test and computerized comprehensive attention test. "
|4.||Hodgkin Disease (Hodgkin's Disease)
05/01/2012 - "Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study."
05/01/2012 - "Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study."
09/01/2012 - "A pharmacokinetic approach to assess artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria."